Analyst Alerts: MAKO Surgical, Under Armour, Altera, E TRADE, Microsoft April 16th
Microsoft Corporation (NASDAQ:MSFT): RBC Capital believes that Microsoft is benefiting from strong enterprise spending on its products, and the firm expects the company to experience favorable pricing trends. The firm raised its target on Microsoft to $34 from $32 and maintains an Outperform rating.
MAKO Surgical Corp. (NASDAQ:MAKO): Piper Jaffray notes the FDA announced late last week the approval of Pipeline Orthopaedics’ 510k application for the Pipeline Total Hip System. Piper expects the hip, which was developed for Mako Surgical (NASDAQ:MAKO), to be received favorably by U.S. surgeons. The firm said it in a note to investors this morning that it remains a buyer of Mako shares at current levels.
Under Armour, Inc. (NYSE:UA): Canaccord recommends buying Under Armour ahead of the April 20 Q1 report. The firm believes its 25c above Street estimate could prove conservative given strong top line trends and robust demand. The firm rates shares a Buy with a $106 price target, up from $102.
Altera Corp. (NASDAQ:ALTR): Goldman believes Altera will provide in-line guidance and should trade higher given negative sentiment and notes shares are not pricing in a recovery.
E TRADE Financial Corporation (NASDAQ:ETFC): After E-Trade’s (NASDAQ:ETFC) stock dropped 6% on Friday, Wells Fargo believes the decline was due to a read-through from JP Morgan (NYSE:JPM), which had to move $1.6B of mostly current second lien loans to non-performing status. However, Wells Fargo doesn’t expect any such accounting change to have a significant impact on E-Trade’s results, and it maintains an Outperform rating on the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.